News Briefing channel feed – Endpoints News

News Briefing channel feed

Gilde Healthcare's €140M; EMD Serono to move US HQ to Boston; Arcturus up for $35M milestone

Last year

Almirall’s new AI deal with Absci; Jazz partners with Autifony; SAB raises $67M

Last year

Teva's new royalty deal; Selecta merges with Cartesian; Vir's hepatitis data

Last year

Vor shares new data for stem cell therapy; Melinta partners with Venatorx on antibiotic under FDA review

Last year

Intellia plans to file IND for AATD trial next year; Ascidian raises $40M

Last year

Pyxis Oncology lays off 20 employees; Xencor’s royalty sale to a pension plan; Jazz partners with MD Anderson

Last year

Sage’s PPD drug to cost $15K; Abcam shareholders vote 'yes' on Danaher deal

Last year

Zentalis shakes up PhIII plans in ovarian cancer; Halozyme's deal with Acumen; Korro's $117M private placement

Last year

Outlook to conduct another trial for wet AMD drug; Cara strikes new royalty deal

Last year

Protagonist's $50M milestone; Swiss biotech raises $27M; Kymera halts a PhI

Last year

Tonix's depression fail; Lilly exercises option in Sitryx deal; Milner stops fight against Abcam acquisition

Last year

Galera considers 'strategic' options; Novo partners with French biotech; AnHeart gets $40M

Last year

Vyne aims to raise $88M; Sanofi invests in gene therapy company; 4DMT addresses clinical hold

Last year

Intas to pay €42M upfront in Henlius deal; Kymera gets $40M milestone; Pluvicto no longer in short supply

Last year

Excision’s HIV gene editing clinical trial; Nykode’s $45M placement; Ideaya’s post-ESMO offering

Last year

BrainStorm to lay off workers; Lilly inks a subcutaneous deal

Last year

Harpoon, Aligos announce PIPEs; NAYA's all-stock deal; Invea to go public

Last year

Keytruda's cervical cancer data; Arcutis’ offering; Alaya.bio announces a CAR-T deal

Last year

Chan Zuckerberg’s new center in New York; Endeavor buys rights to ADC; Basilea acquires antifungal

Last year

Ligand pays $30M upfront in royalty deal; Actym extends its Series A; Gero raises $6M

Last year

Lumen gets $16M for C. diff drug; Flashpoint’s seed round; Amplifier expands Series A

Last year

Nuvalent’s $300M offering; Spark ends epilepsy deal; A small IPO

Last year

Harmony Biosciences' Wakix fails PhIII hypersomnia study; Florida gene therapy startup downsizes

Last year

FDA lifts hold on PepGen's myotonic dystrophy drug; Takeda teams with cancer nonprofit

Last year

First page Previous page 12 13 141516 17 18 Next page Last page